BAKER BROS. ADVISORS LP - Director, 10%+ Owner at Kymera Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director, 10%+ Owner
Issuer Symbol
KYMR on Nasdaq
All Insider Reports
All Insider Reports

BAKER BROS. ADVISORS LP - trading volume in the past year for Kymera Therapeutics, Inc.

Holdings reported by BAKER BROS. ADVISORS LP for Kymera Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 7,955,916 $684,208,776 $86.00 11 Dec 2025 Indirect
Prefunded Warrants 10,225,962 $449,941,305 $44.00 30 Jun 2025 Indirect Common Stock
Non-Qualified Stock Option (right to buy) 16,000 25 Jun 2025 Indirect Common Stock

Transactions reported by BAKER BROS. ADVISORS LP for Kymera Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.